Suppr超能文献

伏格特-小柳-原田综合征的三联免疫抑制治疗

Triple agent immunosuppressive therapy in Vogt-Koyanagi-Harada syndrome.

作者信息

Agarwal Mamta, Ganesh Sudha K, Biswas Jyotirmay

机构信息

Medical Research Foundation, Sankara Nethralaya, Chennai, India.

出版信息

Ocul Immunol Inflamm. 2006 Dec;14(6):333-9. doi: 10.1080/09273940600976938.

Abstract

PURPOSE

To describe the role of triple agent immunosuppression in severe recalcitrant cases of Vogt-Koyanagi-Harada syndrome.

MATERIALS AND METHODS

Retrospective chart review of five cases of Vogt-Koyanagi-Harada syndrome.

RESULTS

All cases were treated with oral prednisolone, azathioprine, and cyclosporine in combination, and rapid remission was observed in all patients. The synergistic effect of the triple agent immunosuppressives helped in preventing recurrences. Prolonged treatment with steroid sparing immunosuppressives in severe and recalcitrant cases of Vogt-Koyanagi-Harada syndrome maintained disease remission.

CONCLUSION

Severe cases of Vogt-Koyanagi-Harada syndrome can be treated with early use of high-dose triple agent immunosuppressives.

摘要

目的

描述三联免疫抑制疗法在重度顽固性Vogt-小柳-原田综合征病例中的作用。

材料与方法

对5例Vogt-小柳-原田综合征病例进行回顾性病历审查。

结果

所有病例均接受口服泼尼松龙、硫唑嘌呤和环孢素联合治疗,所有患者均观察到快速缓解。三联免疫抑制剂的协同作用有助于预防复发。在重度顽固性Vogt-小柳-原田综合征病例中,使用类固醇节省免疫抑制剂进行长期治疗可维持疾病缓解。

结论

重度Vogt-小柳-原田综合征病例可早期使用高剂量三联免疫抑制剂进行治疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验